Ischemic Stroke: Basic Pathophysiology and Neuroprotective Strategies
暂无分享,去创建一个
Eng H. Lo | Turgay Dalkara | Michael A. Moskowitz | M. Moskowitz | E. Lo | A. Singhal | T. Dalkara | Aneesh B. Singhal
[1] F. Buonanno,et al. A pilot study of drug-induced hypertension for treatment of acute stroke , 2001, Neurology.
[2] F. Cheng,et al. Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. , 2002, Life sciences.
[3] J. Stamler,et al. Mechanism of covalent modification of glyceraldehyde‐3‐phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents , 1994, FEBS letters.
[4] O. Witte,et al. Cortical Spreading Depression Induces Proinflammatory Cytokine Gene Expression in the Rat Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] L Persson,et al. The Effect of MK-801 on Cortical Spreading Depression in the Penumbral Zone following Focal Ischaemia in the Rat , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] M. Mattson,et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.
[7] V. Perry,et al. Monocyte Chemoattractant Protein-1 Deficiency is Protective in a Murine Stroke Model , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] P. Chan. Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] E. Connolly,et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. , 1996, The Journal of clinical investigation.
[10] B. Freeman,et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Baron,et al. Mapping the ischaemic penumbra with PET: a new approach. , 2001, Brain : a journal of neurology.
[12] J. Baron,et al. Perfusion Thresholds in Human Cerebral Ischemia: Historical Perspective and Therapeutic Implications , 2001, Cerebrovascular Diseases.
[13] G. Feuerstein,et al. Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. , 1987, Stroke.
[14] R. Busto,et al. Human Albumin Therapy of Acute Ischemic Stroke: Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window , 2001, Stroke.
[15] John H. Zhang,et al. Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model , 2002, Brain Research.
[16] M. Biros,et al. Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. , 2001, Journal of neurosurgery.
[17] H. Diener,et al. Organization of Stroke Care: Education, Referral, Emergency Management and Imaging, Stroke Units and Rehabilitation , 2003, Cerebrovascular Diseases.
[18] A. Thiel,et al. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. , 2001, Brain : a journal of neurology.
[19] Günther Deuschl,et al. Therapeutic Window for Use of Hyperbaric Oxygenation in Focal Transient Ischemia in Rats , 2004, Stroke.
[20] M. Ross,et al. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Salvesen. A lysosomal protease enters the death scene. , 2001, The Journal of clinical investigation.
[22] S. Campbell,et al. Reduction of excitotoxicity and associated leukocyte recruitment by a broad‐spectrum matrix metalloproteinase inhibitor , 2004, Journal of neurochemistry.
[23] Voon Wee Yong,et al. Matrix metalloproteinases and diseases of the CNS , 1998, Trends in Neurosciences.
[24] N. Wahlgren,et al. Clomethiazole Acute Stroke Study (CLASS) Results of a Randomized, Controlled Trial of Clomethiazole Versus Placebo in 1360 Acute Stroke Patients , 1998 .
[25] John H. Zhang,et al. Effect of hyperbaric oxygen on striatal metabolites: a microdialysis study in awake freely moving rats after MCA occlusion , 2001, Brain Research.
[26] W. Hacke,et al. Tolerability of NXY-059 at Higher Target Concentrations in Patients With Acute Stroke , 2003, Stroke.
[27] Tatsuro Mori,et al. Effects of Normobaric Hyperoxia in a Rat Model of Focal Cerebral Ischemia—Reperfusion , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[28] G. Hankey,et al. Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I): Final Results , 2002, Stroke.
[29] M. Fisher. Recommendations for Advancing Development of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable 3 , 2003, Stroke.
[30] M. Kirk,et al. Hyperbaric Oxygen Therapy in Acute Ischemic Stroke: Results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study , 2003, Stroke.
[31] M. Ginsberg,et al. On ischemic brain injury in genetically altered mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[32] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[33] O. Sakowitz,et al. Spreading depolarizations occur in human ischemic stroke with high incidence , 2008, Annals of neurology.
[34] P. Nicotera,et al. Energy Requirement for Caspase Activation and Neuronal Cell Death , 2000, Brain pathology.
[35] T. Coleman,et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. , 2000, Blood.
[36] G. Zoppo. Why do all drugs work in animals but none in stroke patients ? 1 Drugs promoting cerebral blood flow , 1995 .
[37] C. Maier,et al. Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke , 2002, Neuroscience.
[38] W. Hacke,et al. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. , 1998, Stroke.
[39] B. Dunn,et al. Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. , 2009, Stroke.
[40] E. Lo,et al. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation , 2002, Progress in Neurobiology.
[41] M. Moskowitz,et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Bennett,et al. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[43] H. Aburatani,et al. Genome-Wide Gene Expression Analysis for Induced Ischemic Tolerance and Delayed Neuronal Death following Transient Global Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] P. Huang,et al. Nitric oxide is involved in ischemia-induced apoptosis in brain: a study in neuronal nitric oxide synthase null mice , 2001, Neuroscience.
[45] T. Oury,et al. Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia , 1999, Neuroscience.
[46] L. Wilkins. Clinical Trial of Nimodipine in Acute Ischemic Stroke , 1992 .
[47] R. Sobel,et al. Mild Hypothermia Inhibits Nuclear Factor-κB Translocation in Experimental Stroke , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[48] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[49] Robert M Friedlander,et al. Apoptosis and caspases in neurodegenerative diseases. , 2003, The New England journal of medicine.
[50] K. Sunami,et al. Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery , 2000, Critical care medicine.
[51] Marc Fisher,et al. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.
[52] J. Zivin,et al. Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. , 1991, Archives of neurology.
[53] P. Lyden,et al. The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator–treated stroke (CLASS-T) , 2001, Neurology.
[54] P. Stys,et al. Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[55] D. Stein,et al. Mild hypothermia: therapeutic window after experimental cerebral ischemia. , 1996, Neurosurgery.
[56] S. Yusuf,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[57] B. Kristal,et al. An obligate role for oxygen in the early stages of glutamate-induced, delayed neuronal death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[58] Scott Hamilton,et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.
[59] J. Garcìa,et al. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. , 1995, Stroke.
[60] Klaas Nicolay,et al. Correlation between tissue depolarizations and damage in focal ischemic rat brain 1 Published on the World Wide Web on 12 July 1999. 1 , 1999, Brain Research.
[61] H. Diener,et al. Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. , 2000, Stroke.
[62] G. Boysen,et al. Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model , 1993, Journal of the Neurological Sciences.
[63] C. Moy,et al. The Albumin in Acute Stroke Trial (ALIAS); Design and Methodology , 2007, International journal of stroke : official journal of the International Stroke Society.
[64] P. Carmeliet,et al. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[65] N. Rothwell,et al. Role of IL-1α and IL-1β in Ischemic Brain Damage , 2001, The Journal of Neuroscience.
[66] M. Cuzner,et al. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.
[67] Profiles of glutamate and GABA efflux in core versus peripheral zones of focal cerebral ischemia in mice , 2001, Neuroscience Letters.
[68] J. Mcdonald,et al. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity , 1998, Nature Medicine.
[69] M. A. Jacobs,et al. Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke , 2004, Neuroradiology.
[70] D. Choi,et al. Reducing calcium overload in the ischemic brain. , 1999, The New England journal of medicine.
[71] S. Lipton,et al. Excitotoxins in Neuronal Apoptosis and Necrosis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[72] D. Choi,et al. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia , 1996, Brain Research.
[73] H. Nawashiro,et al. TNF-α Pretreatment Induces Protective Effects against Focal Cerebral Ischemia in Mice , 1997 .
[74] S. Chandler,et al. Matrix metalloproteinases degrade myelin basic protein , 1995, Neuroscience Letters.
[75] S. Bernard,et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. , 2002, The New England journal of medicine.
[76] F. Barone,et al. Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[77] T. Wieloch,et al. Hypothermia Prevents the Ischemia‐Induced Translocation and Inhibition of Protein Kinase C in the Rat Striatum , 1991, Journal of neurochemistry.
[78] V. Wee Yong,et al. Metalloproteinases in biology and pathology of the nervous system , 2001, Nature Reviews Neuroscience.
[79] M. Moskowitz,et al. Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[80] M. Moskowitz,et al. Endothelial Nitric Oxide Synthase-Dependent Cerebral Blood Flow Augmentation by L-Arginine After Chronic Statin Treatment , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[81] D. Liebeskind,et al. Trends in Acute Ischemic Stroke Trials Through the 20th Century , 2001, Stroke.
[82] M. Ginsberg,et al. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke , 1994, Annals of neurology.
[83] U. Laufs,et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. , 1998, Circulation.
[84] Fangyi Zhang,et al. Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.
[85] M. Chopp,et al. Journal of Cerebral Blood Flow and Metabolism Temperature Modulation of Cerebral Depolarization during Focal Cerebral Ischemia in Rats: Correlation with Ischemic Injury , 2022 .
[86] M. Fini,et al. Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[87] K. Takakura,et al. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. , 1998, Stroke.
[88] D. J. Cole,et al. Focal Cerebral Ischemia in Rats: Effects of Induced Hypertension, during Reperfusion, on CBF , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[89] A. Villringer,et al. Transient Ischemic Attacks Before Ischemic Stroke: Preconditioning the Human Brain?: A Multicenter Magnetic Resonance Imaging Study , 2004, Stroke.
[90] J. Seylaz,et al. Reduction of Infarct Volume by Magnesium after Middle Cerebral Artery Occlusion in Rats , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[91] T. Dawson,et al. Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor , 2002, Science.
[92] E. Lo,et al. Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in Rats , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[93] T. Yamashima. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates , 2000, Progress in Neurobiology.
[94] J. Grotta. Why do all drugs work in animals but none in stroke patients? 2 Neuroprotective therapy , 1995, Journal of internal medicine.
[95] John Whitehead,et al. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial , 2000, The Lancet.
[96] P. Lyden,et al. Synergistic Combinatorial Stroke Therapy: A Quantal Bioassay of a GABA Agonist and a Glutamate Antagonist , 2000, Experimental Neurology.
[97] G. Mealing,et al. Novel Injury Mechanism in Anoxia and Trauma of Spinal Cord White Matter: Glutamate Release via Reverse Na+-dependent Glutamate Transport , 1999, The Journal of Neuroscience.
[98] P. Bernardi,et al. A mitochondrial perspective on cell death. , 2001, Trends in biochemical sciences.
[99] M. Fini,et al. Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. , 2002, Journal of neurotrauma.
[100] D. Liebeskind,et al. Reversing Stroke in the 2010s Lessons From Desmoteplase In Acute ischemic Stroke-2 (DIAS-2) CT and MRI approaches , 2009 .
[101] M. Fisher,et al. A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. , 2000, Acta neurochirurgica. Supplement.
[102] G. Mies,et al. Repeated Negative DC Deflections in Rat Cortex following Middle Cerebral Artery Occlusion are Abolished by MK-801: Effect on Volume of Ischemic Injury , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[103] G. Donnan,et al. Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. , 2004, Brain : a journal of neurology.
[104] L. Nowak,et al. Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.
[105] Taku Sugawara,et al. Matrix Metalloproteinase Inhibition Prevents Oxidative Stress-Associated Blood–Brain Barrier Disruption after Transient Focal Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[106] S. Snyder,et al. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. , 1994, Science.
[107] E. Lo,et al. Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats , 2002, Stroke.
[108] D. Tanné,et al. Soluble Intercellular Adhesion Molecule-1 and Risk of Future Ischemic Stroke: A Nested Case-Control Study From the Bezafibrate Infarction Prevention (BIP) Study Cohort , 2002, Stroke.
[109] Junying Yuan,et al. Apoptosis in the nervous system , 2000, Nature.
[110] S. Mohand-Said,et al. Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2 , 2002, The Journal of Neuroscience.
[111] F. Buonanno,et al. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. , 1997, Stroke.
[112] S. Warach,et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.
[113] N. Plesnila,et al. Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[114] K. Mikoshiba,et al. ‘Ischemic tolerance’ phenomenon found in the brain , 1990, Brain Research.
[115] S. Yusuf. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .
[116] W. Hacke,et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. , 1999, Neurology.
[117] M. Limburg,et al. Calcium Antagonists for Ischemic Stroke: A Systematic Review , 2001, Stroke.
[118] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[119] Enlimomab Acute Stroke Trial Investigators. Use of anti-ICAM-1 therapy in ischemic stroke , 2001, Neurology.
[120] K. Arai,et al. Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.
[121] J. Koziol,et al. Focal Cerebral Ischemia Induces Active Proteases That Degrade Microvascular Matrix , 2004, Stroke.
[122] David A Boas,et al. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. , 2007, Brain : a journal of neurology.
[123] M. Moskowitz,et al. Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.
[124] Á. Chamorro,et al. Neutrophil Infiltration Increases Matrix Metalloproteinase-9 in the Ischemic Brain after Occlusion/Reperfusion of the Middle Cerebral Artery in Rats , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[125] G. Boysen,et al. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. , 1999, Stroke.
[126] J. Alger,et al. Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.
[127] I. Herr,et al. CD95 Ligand (Fas-L/APO-1L) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Mediate Ischemia-Induced Apoptosis in Neurons , 1999, The Journal of Neuroscience.
[128] E. Michaelis. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging , 1998, Progress in Neurobiology.
[129] P. Adeleine,et al. Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. , 1995, Stroke.
[130] E. Lo,et al. Induction of Caspase-Mediated Cell Death by Matrix Metalloproteinases in Cerebral Endothelial Cells after Hypoxia—Reoxygenation , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[131] A E Hillis,et al. Restoring blood pressure reperfused Wernicke’s area and improved language , 2001, Neurology.
[132] M. Bennett,et al. Knockdown of AMPA Receptor GluR2 Expression Causes Delayed Neurodegeneration and Increases Damage by Sublethal Ischemia in Hippocampal CA1 and CA3 Neurons , 1999, The Journal of Neuroscience.
[133] M. Chopp,et al. DNA damage and repair in central nervous system injury: National Institute of Neurological Disorders and Stroke Workshop Summary. , 1996, Stroke.
[134] Scott Hamilton,et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.
[135] R. Busto,et al. Lipid Peroxidation In Vivo Induced by Reversible Global Ischemia in Rat Brain , 1984, Journal of neurochemistry.
[136] Alex Rovira,et al. Plasmatic Level of Neuroinflammatory Markers Predict the Extent of Diffusion-Weighted Image Lesions in Hyperacute Stroke , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[137] M. Ginsberg. Hypothermic Neuroprotection in Cerebral Ischemia , 1997 .
[138] M. Woodward,et al. Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial , 2003, Stroke.
[139] S. Warach,et al. Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[140] Astrid A. Ortiz,et al. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels , 2001, Nature Medicine.
[141] G. Steinberg,et al. Mild Hypothermia Attenuates Cytochrome C Release but Does Not Alter Bcl-2 Expression or Caspase Activation after Experimental Stroke , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[142] A. Sorensen,et al. Stability of large diffusion/perfusion mismatch in anterior circulation strokes for 4 or more hours , 2010, BMC neurology.
[143] B R Rosen,et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. , 1999, Radiology.
[144] J. Toole,et al. Oxygen therapy in ischemic stroke. , 2003, Stroke.
[145] K. Rajamani,et al. Stroke precipitated by moderate blood pressure reduction. , 2000, The Journal of emergency medicine.
[146] Eng H. Lo,et al. Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.
[147] T. Olsen,et al. Feasibility and Safety of Inducing Modest Hypothermia in Awake Patients With Acute Stroke Through Surface Cooling: A Case-Control Study: The Copenhagen Stroke Study , 2000, Stroke.
[148] U. Dirnagl,et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? , 1999, Stroke.
[149] D. Krieger,et al. Therapeutic Hypothermia for Acute Ischemic Stroke: What Do Laboratory Studies Teach Us? , 2004, Stroke.
[150] Fuhai Li,et al. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. , 1999, Stroke.
[151] M. Chao,et al. Oligodendrocyte Apoptosis Mediated by Caspase Activation , 1999, The Journal of Neuroscience.
[152] B. Mattsson,et al. Rapid disappearance of zinc positive terminals in focal brain ischemia , 1998, Brain Research.
[153] M. Moskowitz,et al. Attenuated Neurotransmitter Release and Spreading Depression-Like Depolarizations after Focal Ischemia in Mutant Mice with Disrupted Type I Nitric Oxide Synthase Gene , 1998, The Journal of Neuroscience.
[154] Sandra E. Ford,et al. A pilot study of hyperbaric oxygen in the treatment of human stroke. , 1991, Stroke.
[155] Ulrich Dirnagl,et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage , 2009, Brain : a journal of neurology.
[156] E. Lo,et al. Drug delivery to damaged brain , 2001, Brain Research Reviews.
[157] G L Wolf,et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. , 1998, AJNR. American journal of neuroradiology.
[158] J. Beilby,et al. Monocyte Count, But Not C-Reactive Protein or Interleukin-6, Is an Independent Risk Marker for Subclinical Carotid Atherosclerosis , 2004, Stroke.
[159] S. Snyder,et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.
[160] Hans-Christoph Diener,et al. NXY-059 for the treatment of acute ischemic stroke. , 2007, The New England journal of medicine.
[161] B. Meldrum,et al. Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. , 2000, Stroke.
[162] J. Astrup,et al. Inhibition of Cerebral Oxygen and Glucose Consumption in the Dog by Hypothermia, Pentobarbital, and Lidocaine , 1981, Anesthesiology.
[163] M. Moskowitz,et al. The ischemic cascade and mediators of ischemic injury. , 2009, Handbook of clinical neurology.
[164] M. Nedergaard,et al. Brain ion homeostasis in cerebral ischemia. , 1988, Neurochemical pathology.
[165] S. Terakawa,et al. Tissue-Type Plasminogen Activator is Involved in the Process of Neuronal Death Induced by Oxygen–Glucose Deprivation in Culture , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[166] C. Sommer,et al. Neuroprotection by Hyperbaric Oxygenation After Experimental Focal Cerebral Ischemia Monitored by MRI , 2004, Stroke.
[167] M. Fujimura,et al. Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[168] Michael Holzer,et al. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .
[169] G. Fiskum. Mitochondrial participation in ischemic and traumatic neural cell death. , 2000, Journal of neurotrauma.
[170] R. Crowell,et al. Beneficial effects of induced hypertension on experimental stroke in awake monkeys. , 1984, Journal of neurosurgery.
[171] AndrewJ. S. Coats. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.
[172] Ulrich Dirnagl,et al. Ischemic tolerance and endogenous neuroprotection , 2003, Trends in Neurosciences.
[173] K. Liu,et al. Interstitial pO2 in Ischemic Penumbra and Core are Differentially Affected following Transient Focal Cerebral Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[174] K. Welch. Primer on cerebrovascular diseases , 1997 .
[175] R. Morrison,et al. bFGF enhances the protective effects of MK-801 against ischemic neuronal injury in vitro. , 1996, Neuroreport.
[176] K. Lees,et al. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. , 1995, Stroke.
[177] C. Epstein,et al. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[178] S. Lipton,et al. Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.
[179] J. Toole,et al. Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats , 2000, Brain Research.
[180] D. Choi,et al. AMPA receptor activation potentiates zinc neurotoxicity , 1993, Neuron.
[181] Jeffrey L. Saver,et al. Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial , 2004, Stroke.
[182] Jiankun Cui,et al. S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.
[183] Yuan Zhang,et al. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. , 1999, Science.
[184] R. Rothlein,et al. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy , 1995, Neurology.
[185] R. Harbaugh,et al. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. , 1996, Journal of neurosurgery.
[186] A. Clark,et al. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia , 1997, Neuroscience Letters.
[187] C. Prosser,et al. COMPARATIVE ANIMAL PHYSIOLOGY , 1962 .
[188] J. Thiran,et al. Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients , 2002, Stroke.
[189] R. Sacco,et al. Tumor Necrosis Factor Receptor Levels Are Associated With Carotid Atherosclerosis , 2002, Stroke.
[190] M. Moskowitz,et al. Synergistic effects of caspase inhibitors and MK‐801 in brain injury after transient focal cerebral ischaemia in mice , 1998, British journal of pharmacology.
[191] D. Corbett,et al. Persistent Neuroprotection with Prolonged Postischemic Hypothermia in Adult Rats Subjected to Transient Middle Cerebral Artery Occlusion , 2000, Experimental Neurology.
[192] J. Bogousslavsky,et al. Do transient ischemic attacks have a neuroprotective effect? , 2000, Neurology.
[193] F. Nicoletti,et al. Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[194] M Chopp,et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.
[195] S. Warach,et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.
[196] B. Lin,et al. Detection of Free Radical Activity During Transient Global Ischemia and Recirculation: Effects of Intraischemic Brain Temperature Modulation , 1995, Journal of neurochemistry.
[197] M. Mishina,et al. Attenuation of Focal Ischemic Brain Injury in Mice Deficient in the ε1 (NR2A) Subunit of NMDA Receptor , 1998, The Journal of Neuroscience.
[198] Jean-Philippe Thiran,et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients , 2002, Annals of neurology.
[199] D. W. Beck,et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. , 1982, Neurosurgery.
[200] J. Grotta,et al. Stroke program review group: an interim report. , 2008, Stroke.
[201] E. Lo. Experimental models, neurovascular mechanisms and translational issues in stroke research , 2008, British journal of pharmacology.
[202] A. Shuaib,et al. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate , 2000, Neuropharmacology.
[203] D. Choi,et al. NMDA receptor-mediated K+ efflux and neuronal apoptosis. , 1999, Science.
[204] J. Wettstein,et al. White matter ischaemia , 1999, Brain Research Reviews.
[205] E. Connolly,et al. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. , 1997, Circulation research.
[206] W. Paschen. Role of calcium in neuronal cell injury: which subcellular compartment is involved? , 2000, Brain Research Bulletin.
[207] S. Cramer,et al. Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals , 2001, Stroke.
[208] E. Tournier-Lasserve. CACNA1A mutations , 1999, Neurology.
[209] I. Ford,et al. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial , 2004, The Lancet.
[210] R. Bullock,et al. Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. , 1999, Journal of neurosurgery.
[211] L. Goldstein,et al. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. , 2001, JAMA.
[212] Keith Muir,et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.
[213] M. Luby,et al. Acute Stroke Imaging Research Roadmap II , 2008, Stroke.
[214] Weizhao Zhao,et al. Albumin Therapy of Transient Focal Cerebral Ischemia: In Vivo Analysis of Dynamic Microvascular Responses , 2002, Stroke.
[215] D. Krieger,et al. Cooling for Acute Ischemic Brain Damage (COOL AID): An Open Pilot Study of Induced Hypothermia in Acute Ischemic Stroke , 2001, Stroke.
[216] M. Moskowitz,et al. Upregulation of the Fas Receptor Death-Inducing Signaling Complex after Traumatic Brain Injury in Mice and Humans , 2002, The Journal of Neuroscience.
[217] C. Epstein,et al. Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia , 1997, The Journal of Neuroscience.
[218] D. Newell,et al. Combination Therapy with MK-801 and α-Phenyl-tert-butyl-nitrone Enhances Protection against Ischemic Neuronal Damage in Organotypic Hippocampal Slice Cultures , 1996, Experimental Neurology.
[219] R. Auer,et al. Eubaric hyperoxemia and experimental cerebral infarction , 2002, Annals of neurology.
[220] J. Grotta. Combination Therapy Stroke Trial: Recombinant Tissue-Type Plasminogen Activator with/without Lubeluzole , 2001, Cerebrovascular Diseases.
[221] F. Tortella,et al. Delayed Secondary Phase of Peri-Infarct Depolarizations after Focal Cerebral Ischemia: Relation to Infarct Growth and Neuroprotection , 2003, The Journal of Neuroscience.
[222] P. Weinstein,et al. Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats. , 1987, Neurosurgery.
[223] J. Grotta,et al. NXY-059 for acute ischemic stroke. , 2006, The New England journal of medicine.
[224] E. Kanal,et al. The Cortical Ischemic Core and Not the Consistently Present Penumbra Is a Determinant of Clinical Outcome in Acute Middle Cerebral Artery Occlusion , 2003, Stroke.
[225] Rick M Dijkhuizen,et al. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke , 2002, Neurology.
[226] C. Molina,et al. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. , 2003, Journal of neurosurgery.
[227] H. Nawashiro,et al. Preferential Conditions for and Possible Mechanisms of Induction of Ischemic Tolerance by Repeated Hyperbaric Oxygenation in Gerbil Hippocampus , 2001, Neurosurgery.
[228] P. Lyden,et al. Effects of hyperbaric oxygen on neurologic outcome for cerebral ischemia in rats. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[229] S. Lipton,et al. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[230] H. Reichmann,et al. Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke , 2009, Stroke.
[231] J. Ritter. Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group. , 1992, Stroke.
[232] R. Sacco,et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. , 2001, JAMA.
[233] John H. Zhang,et al. Inhibition of Apoptosis by Hyperbaric Oxygen in a Rat Focal Cerebral Ischemic Model , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[234] M. Moskowitz,et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.
[235] A Gregory Sorensen,et al. Assessing tissue viability with MR diffusion and perfusion imaging. , 2003, AJNR. American journal of neuroradiology.
[236] J. Koziol,et al. Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[237] N. Noshita,et al. Manganese Superoxide Dismutase Deficiency Exacerbates Cerebral Infarction After Focal Cerebral Ischemia/Reperfusion in Mice: Implications for the Production and Role of Superoxide Radicals , 2002, Stroke.
[238] Guido Kroemer,et al. Mitochondrial control of cell death , 2000, Nature Medicine.
[239] N. Lassen,et al. TREATMENT OF FOCAL CEREBRAL ISCHEMIA WITH HYPERBARIC OXYGEN , 1964 .
[240] G. Feuerstein,et al. Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia , 2000, Brain pathology.
[241] D. Choi,et al. Ions, cell volume, and apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[242] David A. Boas,et al. Mild Induced Hypertension Improves Blood Flow and Oxygen Metabolism in Transient Focal Cerebral Ischemia , 2008, Stroke.
[243] G Bernardi,et al. Synaptic transmission in the striatum: from plasticity to neurodegeneration , 2000, Progress in Neurobiology.
[244] Fuhai Li,et al. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. , 1997, Stroke.
[245] J. Arenillas,et al. Matrix Metalloproteinase Expression After Human Cardioembolic Stroke: Temporal Profile and Relation to Neurological Impairment , 2001, Stroke.
[246] H. Reulen,et al. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia , 1999, Brain Research.
[247] M. Esiri,et al. White Matter Damage Is Associated With Matrix Metalloproteinases in Vascular Dementia , 2001, Stroke.
[248] Mathias Hoehn-Berlage,et al. Potassium-Induced Cortical Spreading Depressions during Focal Cerebral Ischemia in Rats: Contribution to Lesion Growth Assessed by Diffusion-Weighted NMR and Biochemical Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[249] J. Grotta,et al. Lubeluzole in Acute Ischemic Stroke Treatment: A Double-Blind Study With an 8-Hour Inclusion Window Comparing a 10-mg Daily Dose of Lubeluzole With Placebo , 2000, Stroke.
[250] S. Starkman,et al. Physician-Investigator Phone Elicitation of Consent in the Field: A Novel Method To Obtain Explicit Informed Consent For Prehospital Clinical Research , 2006, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[251] E. Lo,et al. Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases , 2002, Journal of neuroscience research.
[252] Guo-Yuan Yang,et al. Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[253] Christopher Putman,et al. Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:: Prediction of Final Infarct Volume and Clinical Outcome , 2001, Stroke.
[254] Tao Yang,et al. Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab′)2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage with Combination Therapy , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[255] Stuart A. Lipton,et al. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.
[256] H. Weiss,et al. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. , 1990, Archives internationales de pharmacodynamie et de therapie.
[257] Jun Chen,et al. Programmed Cell Death in Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[258] K. Hossmann. Viability thresholds and the penumbra of focal ischemia , 1994, Annals of neurology.
[259] G. Schlaug,et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.
[260] Á. Chamorro. Role of Inflammation in Stroke and Atherothrombosis , 2004, Cerebrovascular Diseases.
[261] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[262] Alain Buisson,et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling , 2001, Nature Medicine.
[263] D. Holtzman,et al. Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury* , 2002, The Journal of Biological Chemistry.
[264] Marcel Leist,et al. Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.
[265] H. Fukasawa,et al. Therapeutic effects of hyperbaric oxygenation on acute focal cerebral ischemia in rats. , 1990, Surgical neurology.
[266] R. Bammer,et al. The MRA-DWI Mismatch Identifies Patients With Stroke Who Are Likely to Benefit From Reperfusion , 2008, Stroke.
[267] F. Welsh,et al. Postischemic Hypothermia Fails to Reduce Ischemic Injury in Gerbil Hippocampus , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[268] J. Ulatowski,et al. A Pilot Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke , 2003, Cerebrovascular Diseases.
[269] M. Moskowitz,et al. Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia , 2001, British journal of pharmacology.
[270] M. Ross,et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[271] John H. Zhang,et al. Dual effect of HBO on cerebral infarction in MCAO rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[272] M. Zeng,et al. Fas-induced caspase denitrosylation. , 1999, Science.
[273] R. R. Smith,et al. Hyperbaric oxygen and cerebral infarction in the gerbil. , 1987, Surgical neurology.